About V5med
V5med Inc. is a medical imaging AI company specializing in lung and cardiac diagnostics through advanced computer vision and deep learning. The company is the first AI-based lung diagnostic software company in Taiwan to receive U.S. FDA 510(k) clearance. V5med's platform leverages low-dose CT (LDCT) imaging and AI algorithms to support early detection and quantification of lung nodules, emphysema, pulmonary fibrosis, and coronary artery calcification in a single scan. Built on over a decade of expertise in high-speed imaging, deep learning, and computer vision, V5med's solutions are clinically validated to increase nodule detection sensitivity by over 95%, with up to 20% improvement in radiologist accuracy. The system is Lung-RADS compatible and optimized for detecting ground-glass nodules (GGNs), making it ideal for lung cancer screening programs and routine chest CT workflows. V5med is backed by V5 Technologies, a global leader in optical metrology and semiconductor inspection systems, bringing deep engineering and image analysis expertise into healthcare AI. The company's solutions are PACS-integrated, vendor-neutral, and scalable across radiology networks and screening centers. V5med has deployed its solutions across hospitals in Taiwan, Japan, Vietnam, Thailand, and Indonesia, and is expanding into North America.
Mission & Story
Mission
Our mission is to make AI-powered diagnostics a core driver of precision medicine and a trusted assistant for clinicians worldwide.
Founding Story
V5med was founded as a healthcare AI startup by V5 Technologies, a global leader in optical metrology and semiconductor inspection systems. The parent company's decade-plus expertise in high-speed imaging, deep learning, and computer vision for semiconductor defect detection was leveraged to create advanced medical imaging AI solutions.
Clinical Focus
Medical conditions and clinical areas addressed by V5med.
Who It Serves
Milestones & Awards
Recent Milestones
Received U.S. FDA 510(k) clearance in March 2025, becoming Taiwan's first AI lung diagnostic software company with FDA clearance. Obtained Taiwan TFDA certification in late 2022. Expanding into North American market.
Awards & Recognition
First AI-based lung diagnostic software company in Taiwan to receive U.S. FDA 510(k) clearance
Key Partnerships
Company Details
- Headquarters
- Hsinchu City, Taiwan
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.